UFP Technologies posted a robust second quarter, achieving record sales and profitability metrics. Growth was driven by acquisitions and organic expansion in the MedTech segment. Gross margin slightly declined due to labor inefficiencies, but adjusted metrics reflected strong operational leverage.
Revenue grew to $151.2 million, a 37% increase from Q2 2024.
Net income rose to $17.2 million, or $2.21 per diluted share.
Adjusted EPS reached $2.50, up 27% year-over-year.
Adjusted EBITDA climbed to $31.8 million, a 33% increase.
UFP Technologies remains optimistic about its growth trajectory with continued investment in capacity, recent acquisitions, and a strong sales pipeline, while acknowledging labor-related headwinds and broader macroeconomic uncertainty.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance